Suppr超能文献

经导管主动脉瓣植入术(TAVI)中经腋入路与其他入路相比的地位——一篇系统评价文章

The Place of Transaxillary Access in Transcatheter Aortic Valve Implantation (TAVI) Compared to Alternative Routes-A Systematic Review Article.

作者信息

Herremans Andries, Stevesyns Dylan Thomas, El Jattari Hicham, Rosseel Michaël, Rosseel Liesbeth

机构信息

Department of Cardiology, Algemeen Stedelijk Ziekenhuis, 9300 Aalst, Oost-Vlaanderen, Belgium.

Faculty of Medicine and Health Sciences, University Gent, 9000 Gent, Oost-Vlaanderen, Belgium.

出版信息

Rev Cardiovasc Med. 2023 May 19;24(5):150. doi: 10.31083/j.rcm2405150. eCollection 2023 May.

Abstract

BACKGROUND

Transfemoral transcatheter aortic valve implantation (TAVI) has proven non-inferior or superior against surgical aortic valve replacement (SAVR) for patients at high, intermediate or low surgical risk. However, transfemoral access is not always feasible in patients with severely atherosclerotic or tortuous iliofemoral arteries. For these cases, alternative access techniques have been developed, such as transcarotid, transcaval, direct aortic or transaxillary access. In recent years, growing preference towards the transaxillary access has emerged. To provide a summary of data available on transaxillary TAVI and compare this approach to other alternative access techniques.

METHODS

A literature search was performed in PubMed by two independent reviewers. Studies reporting the outcome of at least 10 patients who underwent transaxillary TAVI, either in case series or in comparative studies, were included in this review. Articles not reporting outcomes according to the Valve Academic Research Consortium (VARC) 1-3 definitions were excluded.

RESULTS

In total 193 records were found of which 18 were withheld for inclusion in this review. This review reports on the combined data of the 1519 patients who underwent transaxillary TAVI. Procedural success was achieved in 1203 (92.2%) of 1305 cases. Life-threatening, major, and minor bleeding occurred respectively in 4.5% (n = 50 in 1112 cases), 12.9% (n = 143 in 1112 cases) and 8.8% (n = 86 in 978 cases). Major and minor vascular complications were reported in respectively 6.6% (n = 83 in 1256 cases) and 10.0% (n = 105 in 1048 cases) of patients. 30-day mortality was 5.2% (n = 76 out of 1457 cases). At one year follow-up, the mortality rate was 1% (n = 184 out of 1082 cases). Similar 30-day and 1-year mortality is observed in studies that compare with transaxillary, transfemoral or other alternative access techniques ( 0.05).

CONCLUSIONS

A wide application of transaxillary access as an alternative approach for TAVI has emerged. This technique has an excellent procedural success rate up to 92.0%, with low procedural complication rates. Clinical outcome of transaxillary TAVI is comparable to the other alternative TAVI approaches. However, these conclusions are solely based on observational data.

摘要

背景

经股动脉经导管主动脉瓣植入术(TAVI)已被证明在高、中、低手术风险患者中不劣于或优于外科主动脉瓣置换术(SAVR)。然而,对于严重动脉粥样硬化或髂股动脉迂曲的患者,经股动脉入路并不总是可行的。对于这些病例,已经开发了替代入路技术,如经颈动脉、经腔静脉、直接主动脉或经腋动脉入路。近年来,对经腋动脉入路的偏好日益增加。目的是总结经腋动脉TAVI的现有数据,并将该方法与其他替代入路技术进行比较。

方法

由两名独立评审员在PubMed上进行文献检索。本综述纳入了报告至少10例接受经腋动脉TAVI患者结局的研究,包括病例系列研究或比较研究。未根据瓣膜学术研究联盟(VARC)1-3定义报告结局的文章被排除。

结果

共检索到193条记录,其中18条被保留以供本综述纳入。本综述报告了1519例接受经腋动脉TAVI患者的综合数据。1305例中有1203例(92.2%)手术成功。危及生命的大出血、大出血和小出血分别发生在1112例中的4.5%(n = 50)、12.9%(n = 143)和978例中的8.8%(n = 86)。分别有6.6%(1256例中的n = 83)和10.0%(1048例中的n = 105)的患者报告发生了大出血和小血管并发症。30天死亡率为5.2%(1457例中的n = 76)。在一年随访时,死亡率为1%(1082例中的n = 184)。在与经腋动脉、经股动脉或其他替代入路技术比较的研究中观察到相似的30天和1年死亡率(P>0.05)。

结论

经腋动脉入路作为TAVI的替代方法已得到广泛应用。该技术具有高达92.0%的出色手术成功率,手术并发症发生率低。经腋动脉TAVI的临床结局与其他替代TAVI方法相当。然而,这些结论完全基于观察性数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de58/11273050/eaf1c1c1ec37/2153-8174-24-5-150-g1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验